Posted on

Fighting for the right to try psilocybin

Washington Officials Join Cancer Patients In Federal Court Argument Pushing DEA To Allow Psilocybin Access

Back in March, a Seattle doctor sued the Drug Enforcement Administration (DEA) for rejecting an application to use psilocybin in end-of-life treatment for cancer patients.

Now, Washington Officials are supporting the case, since Washington is one of 41 states that’ve passed a “right-to-try” law, which gives terminally ill patients access to investigational medicine in Phase I of the FDA approval process.

“It is entirely consistent with the purpose and language of the state and federal right-to-try laws to include any controlled substances that have completed Phase 1 trials, including Schedule I controlled substances,” said Washington Deputy Solicitor General Peter B. Gonick.

PDF of article

Posted on

DEA supports psychedelic medicine?

DEA Proposes Massive Increase In Marijuana And Psilocybin Production For Research To Develop FDA-Approved Medicines

The Drug Enforcement Administration (DEA) is working to accelerate the development of federally-approved psychedelic medicines!

The agency proposed a huge increase in the production of psilocybin, psilocin, and marijuana with the goal of advancing research and drug development.

The proposed production quotas have increased to 1,500 g for psilocybin and 1,000 g for psilocin – up 2,900% and 1,900% respectively from the initial 50 g quota.